scholarly journals PROMPT: a prospective study to assess efficacy and safety of metyrapone in endogenous Cushing's syndrome

2018 ◽  
Author(s):  
Lynnette Nieman ◽  
Baris Akinci ◽  
Albert Beckers ◽  
Marek Bolanowski ◽  
Felicia Alexandra Hanzu ◽  
...  
1973 ◽  
Vol 55 (5) ◽  
pp. 621-630 ◽  
Author(s):  
Richard L. Eddy ◽  
A.Lloyd Jones ◽  
Paul F. Gilliland ◽  
Jesse D. Ibarra ◽  
John Q. Thompson ◽  
...  

1983 ◽  
Vol 142 (1) ◽  
pp. 16-19 ◽  
Author(s):  
William F. Kelly ◽  
Stuart A. Checkley ◽  
David A. Bender ◽  
Keith Mashiter

SummaryOf 26 patients with active Cushing's syndrome assessed before and at three and 12 months after treatment, 21 had pituitary-dependent disease. Median urinary free Cortisol values (per 24 hours) were 680, 180 and 200 nmol at zero, three and 12 months (normal <270 nmol), with significant improvement (P <0.001) at three and 12 months. Depression on the Hamilton rating scale was significantly less at three months (P <0.01) and at 12 months (P <0.001). We have already demonstrated that some patients with Cushing's syndrome have PSE diagnoses of depression and are more depressed than patients with other pituitary tumours. This is the firmest evidence to date that when Cushing's syndrome occurs it commonly causes depressive illness.


2018 ◽  
Vol 8 (2-3) ◽  
pp. 32-36 ◽  
Author(s):  
Bikha Ram Devrajani ◽  
Samar Raza ◽  
Rubina Khushik ◽  
Syed Zulfiquar Ali Shah ◽  
Sanam Mari ◽  
...  

2014 ◽  
Vol 31 (1) ◽  
pp. 76-86 ◽  
Author(s):  
Samin Alavi ◽  
Maryam Ebadi ◽  
Farid Ghazizadeh ◽  
Mohammad Taghi Arzanian ◽  
Bibishahin Shamsian ◽  
...  

2010 ◽  
Vol 163 (1) ◽  
pp. 129-138 ◽  
Author(s):  
Rossella Libé ◽  
Joël Coste ◽  
Laurence Guignat ◽  
Frédérique Tissier ◽  
Hervé Lefebvre ◽  
...  

ContextACTH-independent macronodular adrenal hyperplasia (AIMAH) is a rare and heterogeneous condition characterized by abnormal steroid production. Cortisol secretion can be regulated by aberrant hormone receptors.ObjectiveA large series of patients with AIMAH were evaluated to provide information on the prevalence and profile of aberrant regulations, in relation with the functional status.Design and patientsThirty-two consecutive patients with AIMAH were prospectively studied: 10 had a Cushing's syndrome (CS), and 22 had a subclinical CS (SCS).MethodsA baseline endocrine evaluation was followed by an in vivo protocol in search of aberrant cortisol responses (seven provocative tests). An acute inhibition test with the somatostatin analog octreotide was also performed.ResultsAt least one aberrant cortisol response was identified in 28 of 32 (87%) patients. The overall prevalence of aberrant responses was independent of the functional status. Responses to the upright posture and to metoclopramide were frequently observed (67 and 56% respectively). A glucagon response was frequently observed in the SCS group (58%). A cortisol inhibition by octreotide was specifically found in the three CS patients who positively responded to the mixed meal, and was observed also in 12 of 13 (92%) patients with SCS.ConclusionsCortisol responses indicative of aberrant receptor expression were highly prevalent in AIMAH. Thorough phenotyping of AIMAH may help uncover the underlying pathophysiology.


2009 ◽  
Vol 158 (2) ◽  
pp. 163-169.e3 ◽  
Author(s):  
Craig M. Pratt ◽  
James A. Reiffel ◽  
Kenneth A. Ellenbogen ◽  
Gerald V. Naccarelli ◽  
Peter R. Kowey

Sign in / Sign up

Export Citation Format

Share Document